In a new draft guidance, issued on October 29, 2025, the FDA proposed major updates to simplify biosimilarity studies and potentially reduce ...

The loser could be out; the winner might be in. There are few guarantees as the former Pac-12 rivals duel in a huge Big Ten matchup.